Piramal Pharma to host analyst meets from June 9
Piramal Pharma announced a schedule of analyst and institutional investor meetings from June 9 to June 11, 2026, pursuant to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. The meetings include a Healthcare Ecosystem Tour by Macquarie Equity Research and an Investor Group Meeting by Motilal Oswal in Mumbai, followed by a virtual InsightX 2026 session by Choice Institutional Equities. Maneesh Sharma, Company Secretary & Compliance Officer, signed the intimation on June 1, 2026.
*this image is generated using AI for illustrative purposes only.
Piramal Pharma has announced a schedule of analyst and institutional investor meetings set to take place from June 9 to June 11, 2026. The company will engage with equity research firms and institutional investors through both physical and virtual modes to discuss its performance and outlook.
The interactions are organized pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule features a Healthcare Ecosystem Tour by Macquarie Equity Research and an Investor Group Meeting by Motilal Oswal, both scheduled to be held physically in Mumbai. The series concludes with a virtual session titled InsightX 2026 hosted by Choice Institutional Equities.
Schedule of Meetings
The following table outlines the specific dates, organizers, and logistics for the upcoming investor interactions:
| Date | Name of Analyst/Investor Meet | Nature of Meeting | Mode | Venue |
|---|---|---|---|---|
| June 9, 2026 | Healthcare Ecosystem Tour by Macquarie Equity Research | Group / One-on-one Meeting (Investor Conference) | Physical | Mumbai |
| June 10, 2026 | Investor Group Meeting by Motilal Oswal | Group / One-on-one Meeting (Investor Conference) | Physical | Mumbai |
| June 11, 2026 | InsightX 2026 by Choice Institutional Equities | Group / One-on-one Meeting (Investor Conference) | Virtual | - |
The company has noted that the dates provided are subject to change due to exigencies on the part of the investors or the company. Maneesh Sharma, Company Secretary & Compliance Officer, signed the intimation on June 1, 2026.
Historical Stock Returns for Piramal Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.33% | -6.99% | +3.12% | -9.71% | -18.84% | -10.04% |
What key growth drivers or strategic initiatives is Piramal Pharma likely to highlight during these meetings?
How might the outcomes of these investor interactions influence the company's stock performance in the short term?
What are analysts' current expectations for Piramal Pharma's financial outlook, and could these meetings lead to revisions?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
